The lobster sign in SAPHO syndrome: unusually extensive osteitis of the anterior chest wall partially responsive to infliximab

Rheumatol Int. 2014 Feb;34(2):281-2. doi: 10.1007/s00296-012-2606-y. Epub 2012 Dec 22.

Authors

Branimir Anić¹, Ivan Padjen, Marko Barešić, Stanko Težak

Affiliation

¹ Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Kispaticeva 12, 10000, Zagreb, Croatia.

PMID: 23263495
DOI: 10.1007/s00296-012-2606-y

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Acquired Hyperostosis Syndrome / diagnosis
Acquired Hyperostosis Syndrome / drug therapy*
Acquired Hyperostosis Syndrome / immunology
Anti-Inflammatory Agents / therapeutic use*
Antibodies, Monoclonal / therapeutic use*
Drug Therapy, Combination
Female
Humans
Infliximab
Middle Aged
Radiography
Radionuclide Imaging
Radiopharmaceuticals
Thoracic Wall / diagnostic imaging
Thoracic Wall / drug effects*
Treatment Outcome
Tumor Necrosis Factor-alpha / antagonists & inhibitors
Whole Body Imaging

Substances

Anti-Inflammatory Agents
Antibodies, Monoclonal
Radiopharmaceuticals
Tumor Necrosis Factor-alpha
Infliximab